Advances in Personalized Cancer Vaccine Development: AI Applications from Neoantigen Discovery to mRNA Formulation
Personalized cancer vaccines are a promising immunotherapy targeting patient-specific tumor neoantigens, yet their design and efficacy remain challenging. Recent advances in artificial intelligence (AI) provide powerful tools to enhance multiple stages of cancer vaccine development. This review syst...
Saved in:
| Main Author: | Hyunseung Kong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-03-01
|
| Series: | BioChem |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2673-6411/5/2/5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antitumor mRNA vaccines based on neoantigens
by: E. V. Starostina, et al.
Published: (2025-01-01) -
A Luciferase-Based Approach for Functional Screening of 5′ and 3′ Untranslated Regions of the mRNA Component for mRNA Vaccines
by: Maria Rubtsova, et al.
Published: (2025-05-01) -
Neoantigen-based mRNA vaccine exhibits superior anti-tumor activity compared to synthetic long peptides in an in vivo lung carcinoma model
by: Cao Minh Nguyen, et al.
Published: (2025-03-01) -
Evaluation of synthetic mRNA with selected UTR sequences and alternative poly(A) tail, in vitro and in vivo
by: Ayoub Medjmedj, et al.
Published: (2025-09-01) -
Quantification and discovery of sequence determinants of protein‐per‐mRNA amount in 29 human tissues
by: Basak Eraslan, et al.
Published: (2019-02-01)